Question

I am a breastfeeding mother and i want to know if it is safe to use Erismodegib? Is Erismodegib safe for nursing mother and child? Does Erismodegib extracts into breast milk? Does Erismodegib has any long term or short term side effects on infants? Can Erismodegib influence milk supply or can Erismodegib decrease milk supply in lactating mothers?

Answer by DrLact: About Erismodegib usage in lactation

No information is available on the clinical use of Erismodegib during breastfeeding. Because Erismodegib is 97% bound to plasma proteins, the amount in milk is likely to be low. However, its half-life is about 28 days and it might accumulate in the infant. The manufacturer recommends that breastfeeding be discontinued during Erismodegib therapy.

Alternate Drugs

Fluorouracil(Dangerous)
Vinorelbine(Dangerous)
Cladribine(Dangerous)
Alemtuzumab(Low Risk)
Dacarbazine(Dangerous)
Rituximab(Low Risk)
Vincristine(Dangerous)
Tamoxifen(Dangerous)
Dasatinib(Unsafe)
Bevacizumab(Low Risk)
Gemcitabine(Dangerous)
Thioguanine(Dangerous)
Mitoxantrone(Dangerous)
Dactinomycin(Dangerous)
Letrozole(Dangerous)
Nilotinib(Unsafe)
Exemestane(Dangerous)
Erlotinib(Unsafe)
Hydroxyurea(Low Risk)
Etoposide(Dangerous)
Trastuzumab(Unsafe)
Docetaxel(Dangerous)
Doxorubicin(Dangerous)
Pazopanib(Unsafe)
Cyclophosphamide(Dangerous)
Ipilimumab(Unsafe)
Cisplatin(Unsafe)
Imatinib(Unsafe)
Cetuximab(Unsafe)
Busulfan(Dangerous)
Nivolumab(Unsafe)
Carboplatin(Dangerous)
Vinblastine(Dangerous)
Paclitaxel(Dangerous)
Bleomycin(Dangerous)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Gemcitabine(Dangerous)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Imatinib(Unsafe)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.